Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
450 participants
INTERVENTIONAL
2021-04-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology: A randomized, controlled, unmasked, inter-level clinical trial (Primary Care-Hospital de Poniente) and multicentre (all health centers attached to the Poniente Health District of Almería) will be carried out with a 6-month follow-up. Patients will be assigned to the teledermatology group (experimental) or the conventional monitoring group in the hospital (control). The patients included in the experimental group will be monitored asynchronously. Baseline characteristics, number of visits to the hospital, health-related quality of life, costs, informal care and satisfaction from the perspective of the Andalusian Public Health System and patients and their caregivers will be analyzed. The generic EuroQol-5D questionnaire (EQ-5D) will be administered to assess health-related quality of life and the SKINDEX-29 quality of life dermatological questionnaire. A cost-utility analysis will be performed to assess whether tele-dermatology is cost-effective in terms of additional cost for additional quality-adjusted life years (QALYs).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions
NCT02122432
Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff
NCT04495036
Application of Telemedicine for Dermatological Emergency Patients
NCT02836665
Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age
NCT03684343
Online Question-answering and Conventional Consultation With a Dermatologist
NCT01969422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Teledermatology
The 221 patients who are included in this group will be monitored from the Primary Care centers.
Teledermatology
The experimental group will be made up of dermatological patients monitored asynchronously.
Conventional monitoring
The 221 patients included in this group will have to visit the dermatologist at the hospital.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teledermatology
The experimental group will be made up of dermatological patients monitored asynchronously.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Having any skin disease.
* 3\. Accept to participate in the study.
Exclusion Criteria
* 2\. Be participating in another study.
* 3\. Refuse to participate in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Almeria
OTHER
Antonio Lopez Villegas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Lopez Villegas
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Lopez-Villegas, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital de Poniente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Poniente
El Ejido, Almeria, Spain
Antonio López-Villegas
El Ejido, Almería, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI_20_12CS Telederma
Identifier Type: REGISTRY
Identifier Source: secondary_id
27/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.